M

Medpace Holdings
D

MEDP

340.30
USD
-4.93
(-1.43%)
مغلق
حجم التداول
25,557
الربح لكل سهم
12
العائد الربحي
-
P/E
27
حجم السوق
10,367,854,082
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    C
    CAH
    -0.340
    (-0.27%)
    127.080 USD
    CNC
    CNC
    -0.780
    (-1.33%)
    57.690 USD
    D
    DVA
    -3.560
    (-2.44%)
    142.340 USD
    E
    EVH
    -0.300
    (-2.79%)
    10.440 USD
    HCA
    HCA
    -4.91
    (-1.53%)
    316.52 USD
    MCK
    MCK
    -5.91
    (-0.98%)
    597.72 USD
    O
    OMCL
    0.070
    (0.18%)
    39.720 USD
    T
    THC
    -7.600
    (-5.54%)
    129.670 USD
    U
    UHS
    -4.190
    (-2.28%)
    179.980 USD
    المزيد
الأخبار
المقالات

العنوان: Medpace Holdings

القطاع: Healthcare
الصناعة: Diagnostics & Research
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.